3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Unknown
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gastrointestinal
1
Conditions
Colonic Neoplasms
8
Stomach Neoplasms
6
Rectal Neoplasms
6
Ovarian Neoplasms
3
Liver Neoplasms
3
Neoplastic Cells, Circulating
2
Neoplasms
2
Gastrointestinal Stromal Tumors
2
Esophageal Neoplasms
2
Endometrial Neoplasms
2
Colorectal Neoplasms
2
Carcinoma, Renal Cell
2
Carcinoma, Hepatocellular
2
Uterine Cervical Neoplasms
1
Urinary Incontinence
1
Sexual Dysfunction, Physiological
1
Prostatic Neoplasms
1
Polycystic Ovary Syndrome
1
Pancreatic Neuroendocrine Tumors
1
Pancreatic Neoplasms
1
Obesity, Morbid
1
Myofibroma
1
Melanoma
1
Lymphatic Metastasis
1
Locally Advanced Pancreatic Adenocarcinoma
1
Liver Diseases
1
Kidney Neoplasms
1
Gynecological Cancer
1
Genital Diseases, Female
1
Gastrointestinal Neoplasms
1
Interventions
lenvatinib
2
Liver Transplantation
2
Blood Specimen Collection
2
Antibodies
2
sintilimab
1
camrelizumab
1
Sufentanil
1
Ropivacaine
1
Portasystemic Shunt, Transjugular Intrahepatic
1
Patient Navigation
1
Nutritional Status
1
Magnetic Resonance Imaging
1
Laparoscopy
1
Ketorolac
1
High-Energy Shock Waves
1
Exercise
1
Electroporation
1
Control Groups
1
Analgesia, Epidural
1
Acetaminophen
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase NA
×
Liver Diseases
×
Laparoscopy
×
Clear all
NCT01567631
2016-02-01
LAHIGA
Southwest Hospital, China
Phase NA
Unknown
80 enrolled